View by Category

DR MICHAEL HARNOY PowerPoint PPT Presentations

Show:
Sort by:
In a preliminary Phase I/II study of AlloStimTM in patients with various solid metastatic tumors, Dr. Michael Har-Noy reported encouraging survival data. Out of the 42 patients studied, Dr. Michael Har-Noy said that the subset of five HER2+ breast cancer patients had a median survival of 416 days – markedly longer than the predicted survival of 60 days or less. These five HER2+ patients had high levels of interleukin 12 – an apparent marker for a positive response. Dr. Michael Har-Noy intends to conduct a pivotal Phase II/III trial of AlloStimTM in metastatic breast cancer patients.
| PowerPoint PPT presentation | free to download
Preliminary data show that AlloStimTM and CRCL-AlloVaxTM, two proprietary compounds developed by Dr. Michael Har-Noy, have activity against a wide variety of malignancies. Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., a biotechnology company in Israel, says that he is planning phase I/II trials of AlloStimTM in hepatocellular carcinoma and in head and neck malignancies. Dr. Michael Har-Noy is also designing phase II/III marketing trials for his drugs in patients with HER2+ breast cancer and KRAS gene positive colon cancer. Please visit www.immunocare.net for more information.
| PowerPoint PPT presentation | free to download
Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, Ltd., notes that CAR-T therapy can produce serious toxic reactions, the worst of which is a cytokine release syndrome that causes symptoms similar to those of septic shock.
| PowerPoint PPT presentation | free to download
Dr. Michael Har-Noy founder and CEO of Immunovative Therapies, Ltd., is devising unique methods cancer therapy. Dr. Michael Har-Noy has spent his career formulating immunologic drugs that may benefit millions of victims of cancer. Three of Dr. Michael Har-Noy’s prototype drugs, AlloStimTM, CryoStimTM, and AlloVaxTM, have the potential to completely eliminate different types of cancer cells at any stage of growth. These unique drugs may truly revolutionize the way oncology is practiced.
| PowerPoint PPT presentation | free to download
PowerPlugs
PowerPlugs